Infections Related to Vascular Access Devices

Abstract

Get full access to this article

View all access options for this article.

References

Broviac

J.W.

, Scribner

B.H.

Prolonged parenteral nutrition in the home. Surg Gynecol Obstet. 1974; 139: 24–28.

Hickman

R.P.

, Buckner

C.D.

, Clift

R.A.

A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet. 1979; 148: 871–875.

Maki

D.G.

Reactions associated with midline catheters for intravenous access. Ann Intern Med. 1995; 123: 884–886.

Maki

D.G.

, Bush

, Whitman

E.D.

Real-life VAD infection dilemmas: first step towards consensus. NAVAN Annual Conference, September 1994, San Francisco, Calif. Pg 1.

Raad

I.I.

, Bodey

G.P.

Infectious complications of indwelling vascular catheters. Clin Infect Dis. 1992; 15: 197–208.

Jansen

Vascular catheter-related infection: aetiology and prevention. Curr Opin Infect Dis. 1993; 6: 526–531.

Raad

, Costerton

, Sabharwal

Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993; 168: 400–407.

Rupp

M.E.

, Archer

G.L.

Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis. 1994; 19: 231–243.

Carde

, Cosset-Delaigue

M.F.

, Laplanche

Classical external indwelling central venous catheters versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol. 1989; 25: 939–944.

10.

Groeger

J.S.

, Lucas

A.B.

, Coit

A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg. 1993; 218: 206–210.

11.

Goetz

A.M.

, Muder

R.R.

, Wagener

M.M.

Risk of infection due to femoral placement of central venous catheters. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology. Abstract J6.

12.

Verghese

, Widrich

W.C.

, Arbeit

R.D.

Central venous septic thrombophlebitis: the role of medical therapy. Medicine. 1985; 64: 394–400.

13.

Pizzo

P.A.

Anticipated treatment is the best guide to catheter choice. Oncol Times. 1992; 14: 2.

14.

Raaf

J.H.

Results from use of 826 vascular access devices in cancer patients. Cancer. 1985; 55: 1312–1321.

15.

Press

O.W.

, Ramsey

P.G.

, Larsen

E.B.

Hickman catheter infections in patients with malignancies. Medicine. 1984; 63: 189–200.

16.

Herwaldt

L.A.

, Geiss

, Kao

The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis. 1996; 22: 14–20.

17.

Froggatt

J.W.

, Johnston

J.L.

, Galetto

D.W.

Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother. 1989; 33: 460–466.

18.

Raad

I.I.

, Sabbagh

M.F.

Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis. 1992; 14: 75–82.

19.

Centers for Disease Control and Prevention. Draft guidelines for prevention of intravascular device-related infections. Federal Register. September 27, 1995; 60: 49978–50006.

20.

Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989–1993. MMWR Morb Mortal Wkly Rep. 1993; 42: 597–599.

21.

Bochud

P.Y.

, Calandra

, Francioli

Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med. 1994; 97: 256–264.

22.

Blue

S.R.

, Singh

V.R.

, Saubolle

M.A.

Bacillus licheniformis bacteremia: five cases associated with indwelling central venous catheters. Clin Infect Dis. 1995; 20: 629–633.

23.

Ascher

D.P.

, Zbick

, White

Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis. 1991; 13: 1048–1052.

24.

Arnow

P.M.

, Quimosing

E.M.

, Beach

Consequences of intravascular catheter sepsis. Clin Infect Dis. 1993; 16: 778–794.

25.

Goodrich

J.M.

, Reed

E.C.

, Mori

Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. Clin Infect Dis. 1991; 164: 731–740.

26.

Nguyen

M.H.

, Peacock

J.E.

Jr , Tanner

D.C.

Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective, observational study. Arch Intern Med. 1995; 155: 2429–2435.

27.

Lecciones

J.A.

, Lee

J.W.

, Navarro

E.E.

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis. 1992; 14: 875–883.

28.

Walsh

T.J.

Evolving patterns of nosocomial and community-acquired deep mycosis: analogies to other infections and implications for practitioners. Infect Dis Clin Pract. 1994; 3: S103–S112.

29.

Rex

J.H.

, Bennett

J.E.

, Sugar

A.M.

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med. 1994; 331: 1325–1330.

30.

Saral

Candida and aspergillus infections in immunocompromised patients: an overview. Rev Infect Dis. 1991; 13: 487–492.

31.

Wey

S.B.

, Mori

, Pfaller

M.A.

Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med. 1988; 148: 2642–2645.

32.

Pfaller

M.A.

Epidemiology and control of fungal infections. Clin Infect Dis. 1994; 19(suppl 1): S8–S13.

33.

Fraser

V.J.

, Jones

, Dunkel

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis. 1992; 15: 414–421.

34.

Armstrong

Treatment of opportunistic fungal infections. Clin Infect Dis. 1993; 16: 1–7.

35.

Whimbey

, Kiehn

T.E.

, Brannon

Bacteremia and fungemia in patients with neoplastic disease. Am J Med. 1987; 82: 723–730.

36.

Swerdloff

J.N.

, Filler

S.G.

, Edwards

J.E.

Jr . Severe candidal infections in neutropenic patients. Clin Infect Dis. 1993; 17: S457–S467.

37.

Lecciones

, Lee

J.W.

, Navarro

E.E.

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis. 1992; 14: 875–883.

38.

Bow

E.J.

, Loewen

, Cheang

M.S.

Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenic role of the antileukemic regimen. Clin Infect Dis. 1995; 21: 361–369.

39.

Verfaillie

, Weisdorf

, Haake

Candida infections in bone marrow transplant recipients. Bone Marrow Transplant. 1991; 8: 177–184.

40.

Goodman

J.L.

, Winston

D.G.

, Greenfield

R.A.

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992; 326: 845–851.

41.

Wingard

J.R.

Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis. 1995; 20: 115–125.

42.

Anaissie

Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis. 1992; 14(suppl 1): S43–S53.

43.

Mermel

L.A.

Prevention of intravascular catheter-related infections. Infect Dis Clin Pract. 1994; 3: 391–398.

44.

Raad

I.I.

, Hohn

D.C.

, Gilbreath

B.J.

Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994; 15: 231–238.

45.

Circeo

, McGee

, Brown

R.B.

Management of infections in adult intensive care unit patients: Part II. Infect Dis Clin Pract. 1995; 3: 254.